CP-Pharma Handelsgesellschaft mbH is a family-owned veterinary pharmaceutical company based in Burgdorf, Germany. Founded in 1977, it develops, manufactures, and distributes a wide range of veterinary medicinal products tailored to the needs of various animal species.
The company holds more than 180 marketing authorizations in Germany and maintains a broad portfolio covering antibiotics, antiparasitics, anthelmintics, non-steroidal anti-inflammatory drugs such as firocoxib, anaesthetics, hormones, vitamins, and other therapeutic categories. It emphasizes continuous research and development to provide high-quality generics and innovative formulations at competitive prices.
Primarily operating in the German market, CP-Pharma engages directly with veterinary practices and clinics through approximately 25,000 annual visits, achieving a 94% repeat customer rate among its over 70 employees. It also exports products to other European countries.
As a family business under the Gessert family ownership, the company positions itself as a significant player in the German veterinary industry, offering pragmatic alternatives to larger multinational corporations while focusing on customer service, product quality, and accessibility for veterinarians.
Also known as CP Pharma.
Decisions on multiple vaccines and label changes; amended residue entry; extended amoxicillin advice timetable with a 2‑month public consultation; new guidance consultations and appointments.